Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial

Talluri Ronnie Abhishek; Md Hasnat Ali; May Zun Aung Win; Somsiri Sukavatcharin; Anup Kelgaonkar; Soumyava Basu

doi:10.1080/08820538.2025.2599224

Abstract

Six-month ATT is non-inferior to 9-month ATT for treating tubercular posterior uveitis, though it may vary between the different clinical phenotypes.

Affiliated Institutions

Related Publications

Impact of Community Intervention to Reduce Patient Delay Time on Use of Reperfusion Therapy for Acute Myocardial Infarction Rapid Early Action for Coronary Treatment (REACT) Trial

Jerris R. Hedges , Henry A. Feldman , Vera Bittner +9 more

Abstract. Background: Reperfusion therapy for acute myocardial infarction (AMI) is a time‐dependent intervention that can reduce infarct‐related morbidity and mortality. Out‐of‐...

2000 Academic Emergency Medicine 71 citations

Compliance with cardiovascular disease prevention strategies: A review of the research

Lora E. Burke , Jacqueline Dunbar‐Jacob , Michael D. Hill

The efficacy of cardiovascular risk-reduction programs has been established. However, the extent to which risk-reduction interventions are effective may depend on adherence. Non...

1997 Annals of Behavioral Medicine 283 citations

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

<h3>Abstract</h3> <b>Objective</b>: To determine the effects of “prolonged” antiplatelet therapy (that is, given for one month or more) on “vascular events” (non-fatal myocardia...

1994 BMJ 3110 citations

Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices

Gregg C. Fonarow , Nancy M. Albert , Anne B. Curtis +10 more

Background— A treatment gap exists between heart failure (HF) guidelines and the clinical care of patients. The Registry to Improve the Use of Evidence-Based Heart Failure Thera...

2010 Circulation 417 citations

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma , Robert Olson , Stephen Harrow +19 more

The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled tr...

2019 The Lancet 1754 citations

Publication Info

Year: 2025
Type: article
Pages: 1-7
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Talluri Ronnie Abhishek, 
                                
                                    Md Hasnat Ali, 
                                
                                    May Zun Aung Win
                                
                                et al.
                            
                            (2025). 
                            Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial. 
                            Seminars in Ophthalmology
                            
                            , 1-7.
                            https://doi.org/10.1080/08820538.2025.2599224

Identifiers

DOI: 10.1080/08820538.2025.2599224